Latest news

October 25, 2023

Debiopharm invests over 30 million on innovation when its workforce jumped 33% in Valais in one year

Read more
October 24, 2023

Transfer of Marketing Authorization of Anticancer Drug Elplat® to Takata Pharmaceutical

Read more
September 28, 2023

Debiopharm Innovation Fund Launches New Seed Funding Activity to accelerate digital transformation of cancer care and Pharma R&D

Read more
September 26, 2023

Debiopharm Recognizes Pioneering Japanese Cancer Research During The 82nd JCA-Mauvernay Award Ceremony

Read more
September 21, 2023

Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-Treat Cancers

Read more
September 6, 2023

Debiopharm joins discussions with international health organisations to fight anti-microbial resistance at the 2023 World AMR Congress

Read more
July 6, 2023

Debiopharm Launches “Oncolifestyle” website in Switzerland for People Living with Cancer

Read more
July 3, 2023

8e Challenge Qualité de vie du patient : cinq finalistes reçoivent 5000 francs chacun et avancent en finale

Read more
June 21, 2023

Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical…

Read more

Stay informed

Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.